Join
Live feed
·
PRReleasevia Quantisnow
Vor Biopharma Inc. logo

Telitacicept Receives NMPA Approval for the Treatment of Sjögren's Disease in China

ByQuantisnow·Wall Street's wire, on your screen.
VOR· Vor Biopharma Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VOR (Vor Biopharma Inc.) and more on Quantisnow.